Robert Andrade - 04 Jan 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
04 Jan 2024
Net transactions value
-$315,750
Form type
4
Filing time
05 Jan 2024, 17:24:33 UTC
Previous filing
30 Jun 2023
Next filing
27 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale $159,600 -15,000 -10% $10.64 134,721 04 Jan 2024 Direct F1
transaction FENC Common shares Sale $156,150 -15,000 -11% $10.41 119,721 05 Jan 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023.
F2 Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023.